ArticleFrontiers in oncology2024

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma.

Sandra Llop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.